Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
1372.00
Change Change %
-17.90 -1.29%

Updated:15 Oct, 2019, 13:59 PM IST

BSE
1371.10
Change Change %
-18.15 -1.31%

Updated:15 Oct, 2019, 14:11 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Edelweiss
N/A
22-09-2019 Buy 1323.00 1475.00
N/A
Open Short (1M)
22-10-2019

Edelweiss Recommends 'Buy' On Dr Lal PathLabs

According to Edelweiss, Dr Lal PathLabs has the best Return on Capital Employed (RoCE), asset turnover and working capital. The company's strategy is to expand its presence in pathology, diversify away from Delhi NCR and explore inorganic growth, the brokerage adds.

Top